10 Jun 2020 17:43
EKF Diagnostics Holdings plc
("EKF" or the "Company")
Results of AGM
EKF Diagnostics Holdings (AIM: EKF), the AIM quoted point-of-care business, announces that at the Annual General Meeting ("AGM") held earlier today, all resolutions were duly passed.
The results of the AGM is available on the Company website: https://www.ekfdiagnostics.com/
Enquiries:
EKF Diagnostics Holdings plc | www.ekfdiagnostics.com |
Christopher Mills, Non-Executive Chairman | Tel: 029 2071 0570 |
Julian Baines, CEO | |
Richard Evans, FD & COO | |
N+1 Singer (Nomad & Broker) | Tel: 020 7496 3000 |
Aubrey Powell / George Tzimas (Corporate Finance) Tom Salvesen (Corporate Broking) | |
Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com | |
Paul McManus/ Lianne Cawthorne | Mob: 07980 541 893 / 07584 391 303 |
About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)
EKF is a leading point-of-care diagnostics and central laboratory assay manufacturer with an estimated 80,000 hemoglobin, hematocrit, HbA1c, glucose and lactate analyzers in regular use across more than 100 countries. EKF specializes in developing tests for use in anemia and diabetes diagnosis and management, as well as providing a portfolio of reagents for use in clinical chemistry analyzers.
Ekf Diagnostics (EKF)